Results
eNauka >
Rezultati >
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II
| Naziv: | Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II | Autori  : | Reinisch, Walter; ...; Tarabar, Dino K; ...; (broj, koautora 18) | Godina: | 2021 | Publikacija: | JOURNAL OF CROHNS & COLITIS | ISSN: | 1873-9946 Journal of Crohn#s and Colitis Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 15 br. 6 str. 938-949 | DOI: | 10.1093/ecco-jcc/jjab023 | WoS-ID: | 000670981200005 | Scopus-ID: | 2-s2.0-85109044031 | PMID: | 33599720 | PMCID: | PMC8218706 | URI: | https://enauka.gov.rs/handle/123456789/823010 | Projekat: | Shire Shire International GmbH Pfizer |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.